Trial Profile
Phase 1b/2 study of VeriStrat in advanced non-small cell lung cancer patients with cabozantinib +/- erlotinib
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 13 Oct 2015
Price :
$35
*
At a glance
- Drugs Cabozantinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.
- 08 Sep 2015 New trial record